Cargando…

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression

The incidence of thyroid cancer remains high worldwide, and papillary thyroid cancer (PTC) is the most common type. Potassium Calcium-Activated Channel Subfamily N Member 4 (KCNN4) has been reported as an oncogene in various cancers. We examined expression of KCNN4 in public databases and discovered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jialiang, Lin, Bangyi, Lin, Lizhi, Chen, Yizuo, Wang, Ouchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485723/ https://www.ncbi.nlm.nih.gov/pubmed/32857728 http://dx.doi.org/10.18632/aging.103710

Ejemplares similares

Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer
por: Lin, Lizhi, et al.
Publicado: (2020)

Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
por: Wen, Jialiang, et al.
Publicado: (2020)

The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway
por: Zheng, Danni, et al.
Publicado: (2022)

MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer
por: Dong, Si Yang, et al.
Publicado: (2020)

LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma
por: Xiang, Jingjing, et al.
Publicado: (2020)

PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer
por: Jin, Lingli, et al.
Publicado: (2021)

KCNN2 polymorphisms and cardiac tachyarrhythmias
por: Yu, Chih-Chieh, et al.
Publicado: (2016)

CLDN10 is Associated with Papillary Thyroid Cancer Progression
por: Zhou, Yili, et al.
Publicado: (2018)

SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis
por: Jin, Lingli, et al.
Publicado: (2021)

Orthodenticle Homeobox OTX1 Promotes Papillary Thyroid Carcinoma Progression and Is a Potential Prognostic Biomarker
por: Wei, Jing, et al.
Publicado: (2023)

CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer
por: Xia, Erjie, et al.
Publicado: (2018)

KCNN4 Promotes the Stemness Potentials of Liver Cancer Stem Cells by Enhancing Glucose Metabolism
por: Fan, Jing, et al.
Publicado: (2022)

APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma
por: Lin, Xu, et al.
Publicado: (2022)

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications
por: Rodrigues, Ana Cunha, et al.
Publicado: (2017)

Kcnn4 Is a Regulator of Macrophage Multinucleation in Bone Homeostasis and Inflammatory Disease
por: Kang, Heeseog, et al.
Publicado: (2014)

Lack of Kcnn4 improves mucociliary clearance in muco-obstructive lung disease
por: Vega, Génesis, et al.
Publicado: (2020)

New KCNN4 Variants Associated With Anemia: Stomatocytosis Without Erythrocyte Dehydration
por: Allegrini, B., et al.
Publicado: (2022)

Evaluation of ITGA3 as a Biomarker of Progression and Recurrence in Papillary Thyroid Carcinoma
por: Zhang, Guoliang, et al.
Publicado: (2022)

LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition
por: Xu, Min, et al.
Publicado: (2021)

Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients
por: Wang, Kun, et al.
Publicado: (2022)

F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer
por: Luo, Jun-Hua, et al.
Publicado: (2022)

PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Wang, Lingli, et al.
Publicado: (2022)

Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis
por: Nakahara, Erina, et al.
Publicado: (2023)

CUX2 functions as an oncogene in papillary thyroid cancer
por: Sun, Yihan, et al.
Publicado: (2018)

Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation
por: Ellinor, Patrick T., et al.
Publicado: (2010)

Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Oncology, Journal of
Publicado: (2023)

Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
por: Wang, Zhiyang, et al.
Publicado: (2023)

KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
por: Zhao, Haiyue, et al.
Publicado: (2016)

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
por: Fuest, Sebastian, et al.
Publicado: (2022)

ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma
por: Lin, Xu, et al.
Publicado: (2021)

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
por: Jin, Langping, et al.
Publicado: (2016)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Shaohua, et al.
Publicado: (2021)

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
por: Zarkesh, Maryam, et al.
Publicado: (2018)

Low expression of KCNN3 may affect drug resistance in ovarian cancer
por: Liu, Xia, et al.
Publicado: (2018)

KCNN2 Mutation in Pediatric Tremor Myoclonus Dystonia Syndrome with Electrophysiological Evaluation
por: Lavenstein, Bennett, et al.
Publicado: (2022)

Serum biomarkers of papillary thyroid cancer
por: Makki, Fawaz M, et al.
Publicado: (2013)

CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
por: Jeong, Young Mun, et al.
Publicado: (2020)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study
por: Chen, Shaohua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7oe9lcudj18godbe3eunvts2ck